X
    X
    X
    X

    Locke Lord Team’s Federal Circuit Win on Behalf of Zydus Highlighted in IP Law 360

    Articles

    Michael Gaertner, Hugh Balsam, James Peterka, David Abramowitz, Andy Miller, Wasim Bleibel, Timothy Peterson (all of Chicago) and Andrea Wayda (New York) successfully represented clients Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited in securing a Federal Circuit decision affirming the district court’s ruling that Zydus’s generic version of Shire Development LLC’s ulcerative colitis drug Lialda does not infringe Shire’s U.S. Patent No. 6,773,720.

    To read the complete article, click here (subscription may be required).

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.